[go: up one dir, main page]

WO1994023017A1 - A composition useful as additive to a cell culture medium, comprising colostrum and serum - Google Patents

A composition useful as additive to a cell culture medium, comprising colostrum and serum Download PDF

Info

Publication number
WO1994023017A1
WO1994023017A1 PCT/FI1994/000089 FI9400089W WO9423017A1 WO 1994023017 A1 WO1994023017 A1 WO 1994023017A1 FI 9400089 W FI9400089 W FI 9400089W WO 9423017 A1 WO9423017 A1 WO 9423017A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture medium
cells
colostrum
composition
less
Prior art date
Application number
PCT/FI1994/000089
Other languages
French (fr)
Inventor
Raimo Antero Pakkanen
Jouni Uolevi Aalto
Harry Gösta JALONEN
Ari Perttu Tapani Kanttinen
Original Assignee
Viable Bioproducts Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viable Bioproducts Ltd. filed Critical Viable Bioproducts Ltd.
Priority to AU62091/94A priority Critical patent/AU6209194A/en
Priority to EP94909138A priority patent/EP0692023A1/en
Publication of WO1994023017A1 publication Critical patent/WO1994023017A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals

Definitions

  • composition useful as additive to a cell culture medium comprising colostrum and serum
  • This invention relates to a novel composition useful as additive to culture media for the cultivation of adherent cells.
  • the invention concerns further novel culture media and their use in the cultivation of such cells.
  • a basal medium In the cultivation of animal cells, a basal medium is traditionally supplemented with mammal blood serum.
  • mammal blood serum contains several partly unknown cell growth promoting agents, such as growth factors, vitamins, trace elements, hormones, binding proteins and attachment factors.
  • a serum suitable for most purposes is fetal bovine serum (FBS). The price of this serum has increased greatly in recent years because of the increasing demand and the limited availability of sufficiently pure sera.
  • FBS can be replaced with newborn calf serum, calf serum or even adult bovine serum.
  • FBS is, however, most effective. This is probably due to its high growth factor content.
  • Other important proteins in serum are attachment factors. These include, for example, fibronectin.
  • Most adherent cell types require additional attachment factors in cell culture medium although some cells can also synthezise them by themselves.
  • the objective of growing animal cells is the production, purification and characterization of secreted compounds such as monoclonal antibodies
  • the use of serum-free medium containing reduced amounts of protein and immunoglobulins makes downstream processing more simple and can greatly improve end-product purification and recovery.
  • bovine colostrum fraction useful as serum substitute for the cultivation of mouse hybridomas for production of monoclonal antibodies. Fractions of bovine colostrum were prepared and their ability to support the growth of mouse-mouse hybridomas in culture was tested. Whey was prepared from defatted colostrum by removal of casein using acid precipitation. An ultrafiltrate was obtained from cleared whey by filtration through membranes with a nominal molecular weight cut-off of 100000 Da.
  • the colostrum ultrafiltrate (colostrum fraction) so obtained contained 1.16 g/1 protein, 0.24 g/1 im unoglobulin G (IgG) and less than 0.24 EU (endotoxin unit)/ml endotoxins.
  • the effect of defatted colostrum, whey and ultrafiltrate as serum substitutes was studied by cultivation of hybridoma cells in minimal essential medium containing different concentrations of supplements. Under optimal conditions in ultrafiltrate-supplemented medium, the maximal cell concentration was 35 - 40 % of that obtained using 10 % fetal bovine serum, and antibody production per cell was equal to that achieved using fetal bovine serum.
  • the results of this study showed that the bovine colostrum ultrafiltrate provides a very attractive alternative to fetal bovine serum for production of monoclonal antibodies.
  • adherent cells An important group of cells used for the production of biochemicals are classified as adherent cells. Animal cells can be divided into two classes according to the manner in which they grow: suspension cells, which grow in suspended form, and adherent cells, which grow attached to a surface. Hybrido a cells are typically suspension cells while most of the other cells could be classified as adherent cells. Typical examples of adherent cells are e.g. Vero (kidney cells of the African Green Monkey), CHO-K1 (ovary cell line of the Chinese hamster) and 3T3-fibroblast. The Vero and CHO-K1-cells are widely used in the biotechnical industry. Vero cells are used in the production of viruses and viral proteins and CHO-K1- and CHO-cells are often used as host cells in large scale production of recombinant proteins.
  • adherent cells e.g. Vero (kidney cells of the African Green Monkey), CHO-K1 (ovary cell line of the Chinese hamster) and
  • Bovine colostrum resembles FBS in the respect that it contains growth factors.
  • the growth factor content of colostrum is high.
  • a colostrum ultrafiltrate could be used to replace FBS in hybridoma cell cultures.
  • colostrum does not contain enough attachment factors for many adherent cells. Such attachment factors can be found in FBS as well as in bovine serum (BS).
  • colostrum ultrafiltrate fraction The effect of the colostrum ultrafiltrate fraction on the growth of adherent cells has also been tested. Vero and CHO-K1 cells were grown in a basal medium containing varying amounts of colostrum ultrfiltrate according to the method described in the paper by R Pakkanen et al. A minor effect could be observed at colostrum ultrafiltrate concentrations ranging from 10 to 15 %, but the effect was very small compared to that caused to the growth of the hybridoma cells.
  • bovine serum contains the important attachment factor fibronectin.
  • fibronectin added to colostrum possesses an advantageous effect on the proliferation of adherent cells.
  • the addition of fibronectin to a colostrum fraction according to this invention did not affect the growth of adherent cells.
  • Another object of the invention is to provide an efficient culture medium for the cultivation of such cells.
  • Yet another object of the invention is to provide a method for the growth of adherent cells, by utilizing the culture medium of the invention.
  • the Figures IA to 6 describes the number of viable cells versus time during continuous cultivation on a culture medium comprising different attachment factor additive compositions and different amounts thereof.
  • the basal media used were DMEM for Vero cells and DMEM- F12 (1:1) for CHO-K1 cells supplemented with glutamine (4 mM), penicillin (100 units/ml) and streptomycin (100 ⁇ g/ml).
  • human transferrin (hTF) was added to the culture medium to give a concentration of 5 mg/1. All the percentages below are vol- %. For further details reference is made to the experiments.
  • Figure IA shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS (•) and 13 % bovine colostrum ultrafiltrate (in the following abbreviated UF) (0).
  • Figure IB shows the number of viable Vero-cells versus time in a culture medium supplemented with 10 % FBS (•) and 13 % colostrum ultrafiltrate (in the following abbreviated UF) (0).
  • Figure 2A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 2 % BS (bovine serum) + 13 % UF (X)
  • Figure 2B shows the number of viable Vero-cells versus time in a culture medium supplemented with
  • Figure 3A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 1 % BS + 13 % UF (0) 1 % BS + 10 % UF (v) 1 % BS + 6.67 % UF ( ⁇ ) 1 % BS + 3.3 % UF (A)
  • Figure 3B shows the number of viable Vero-cells versus time in a culture medium supplemented with 1 % BS + 13 % UF (•) 1 % BS + 10 % UF ( ) 1 % BS + 6.7 % UF ( ⁇ ) 1 % BS + 3.3 % UF (_4)
  • Figure 4A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with
  • Figure 4B shows the number of viable Vero-cells versus time in a culture medium supplemented with 0.5 % BS, no hTF added (t)
  • Figure 5A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 0.5 % FBS, no hTF added (•) 1.0 % FBS, " ( ⁇ ) 2.0 % FBS, no hTH added ( B ) 10 % FBS, no hTF added (_4) 1.0 % BS + 6.7 % UF, 5 mg/1 hTF (0) 0.33 % BS + 6.7 % UF, 5 mg/1 hTF (V) 0.60 % BS + 6.7 % UF, 5 mg/1 hTF (D) 1.0 % BS + 10 % UF, 5 mg/1 hTF ( .) no supplement of BS, UF or hTF added (X)
  • Figure 5B shows the number of viable Vero-cells versus time in a culture medium supplemented with 0.5 % FBS, no hTF added (•)
  • Figure 6 shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS (•) 10 % UF (0) 10 % UF + 65 ⁇ g/ml of fibronectin (D)
  • a composition comprising a colostrum fraction, e.g. the colostrum ultrafiltrate as described in the experiments, and small amounts of serum efficiently enhances the growth of adherent cells when added to the culture medium for said cells.
  • the results obtained clearly exhibit a synergistic effect obtained by combining the two components, i.e. UF and BS. Comparative tests with the addition to the culture medium of plain BS, plain UF and various combinations of UF and BS show that the combinations give an essentially stronger effect on the growth of the adherent cell than what would be expected by adding the effects of the individual components UF and BS.
  • the invention thus provides a composition useful as additive to culture media for the cultivation of adherent cells, said composition comprising
  • colostrum fraction prepared by subjecting colostrum, from which fat and cellular debris have been removed by conventional methods, and from which colostrum optionally also casein has been removed by precipitation, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate, and
  • a serum component in an amount sufficient to enhance the proliferation of cells after the addition of a suitable amount of said composititon to a culture medium.
  • the invention further provides a culture medium useful for the cultivation of adherent cells, said culture medium comprising
  • colostrum fraction prepared by subjecting colostrum, from which fat and cellular debris have been removed by conventional methods, and from which colostrum optionally also casein has been removed by precipitation, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate,
  • the invention further provides a method of promoting proliferation of adherent cells in a culture medium said method comprising contacting an amount of cells with a culture medium according to the invention for a certain period of time.
  • the transferrin present in the serum may be enough.
  • the culture medium must be supplemented by additional transferrin.
  • the colostrum fraction is for practical reasons preferably obtained from bovine colostrum. Colostrum from other sources is, however, also believed to be useful for the preparation of the colostrum fraction to be used in this inventio .
  • the serum component is preferably bovine serum, but other sera such as horse sera are also believed to be effective.
  • the colostrum fraction has an endotoxin content of less than 5 EU/ l (units per ml), a total protein content of less than 4.5 mg/ml and an immunoglobulin content of less than 1.2 mg/ml.
  • compositions of the invention wherein the colostrum fraction has an endotoxin content of 1.0 EU/ml or less, a total protein content of 2.0 mg/ml or less and an immunoglobulin content of 0.25 mg/ml or less.
  • Such a fraction can be obtained by e.g. by subjecting the defatted colostrum to casein precipitation before the ultrafiltration.
  • composition of the invention comprises preferably serum component in an amount of at least 0.5 % of said composition.
  • composition according to the invention can further comprise one or more supplemental agents selected from the group comprising sodium selenite, ethanolamine, ⁇ - mercaptoethanol, bovine serum albumin and transferrin.
  • the culture medium of this invention can be prepared by adding separately appropriate amounts of colostrum fraction and serum to the basal growth medium
  • the culture medium is preferably made by adding to the basal growth medium an appropriate amount of a composition redily including the colostrum fraction and serum component.
  • the composition further includes added amounts of transferrin and optionally also other supplemental agents.
  • the culture medium has a concentration of the colostrum fraction ranging from about 1 % to about 20 % and a serum concentration that is at least 0.1 % of said culture medium.
  • the culture medium has a concentration of the colostrum fraction ranging from about 5 to 15 % of said culture medium.
  • adherent cells such as CH0-K1 (Chinese hamster ovary cells) and Vero (African green monkey kidney cells) as these two represent the technically most important adherent cells.
  • adherent cells such as CH0-K1 (Chinese hamster ovary cells) and Vero (African green monkey kidney cells) as these two represent the technically most important adherent cells.
  • BS bovine serum
  • UF colostrum ultrafiltrate
  • Chinese hamster ovary cells (CHO-K1, ATCC CCL 61) and African green monkey kidney cells (Vero, ATCC CCL 81) were obtained from Flow (Flow Laboratories, Rickmansworth, England) .
  • DMEM Dulbecco's Modified Eagles Essential Medium
  • DMEM-F12 (1:1) DMEM-F12 (1:1) (GIBCO) (for CHO-K1 cells) supplemented with glutamine (4 mM), penicillin (100 units/ml) and streptomycin (100 ⁇ g/ml).
  • GEBCO DMEM-F12 (1:1)
  • Stock cultures were maintained in 75-cm 2 plastic flasks (Cos ar, Cambridge, Mass, USA) supplemented with 10 % FBS (HyClone, Logan, Utah, USA).
  • BS bovine serum
  • FBS fetal bovine serum
  • UF colostrum ultrafiltrate
  • SIGMA human (holo)transferrin
  • the culture supernatants were removed and 150 ⁇ l 2xTE was added to each well. The plates were incubated at 37°C for about 10 min. Then, the culture supernatants were added back to the corresponding wells and the cells were suspended by pipetting the cultures. Cell counts were done in a haemocytometer using trypan blue exclusion to determine viability. Each counting point represents the average cell concentration of duplicate wells, and each well was counted only once.
  • FBS CH0-K1 cells tended to form large clusters and only a small cell population was spread.
  • Maximum growth of Vero cells was obtained in 13 % UF supplemented with 1-2 % BS, whereas no significant differences could be observed in CHO-K1 cultures supplemented with 0.6-2 % BS.
  • UF and BS Vero and CH0-K1 cells were cultured in 1 % BS supplemented with 3.3- 13 % UF and transferrin 5 mg/1.
  • CHO- Kl cells achieved maximum cell density in 6.7 % UF.
  • FIG. 5 shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS, 10 % UF and 10 % UF + 65 ⁇ g/ml of fibronectin. As can be seen from the Figure, fibronectin added to the UF did not have any effect on the cell growth.
  • the colostrum fraction from which casein not has been removed before ultrafiltration which fraction also is useful in the composition and culture medium of the invention, is prepared according to the method described in the paper by R Pakkanen et al. referred to above with the only difference that casein is not precipitated before ultrafiltration.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention concerns a composition useful as additive to culture media for the cultivation of adherent cells, said composition comprising a colostrum fraction and a serum component in an amount sufficient to enhance the proliferation of cells after the addition of a suitable amount of said composition to a culture medium. The invention further concerns culture media comprising a colostrum fraction and serum as well as the use of such culture media for the cultivation of adherent cells.

Description

A composition useful as additive to a cell culture medium, comprising colostrum and serum
FIELD OF THE INVENTION
This invention relates to a novel composition useful as additive to culture media for the cultivation of adherent cells. The invention concerns further novel culture media and their use in the cultivation of such cells.
BACKGROUND OF THE INVENTION
Cell culture media for large-scale production of various biochemicals such as monoclonal antibodies, growth factors, hormones, vaccines and substances to be used in therapy must fulfil several important criteria:
1. Substance production should be continuous and reproducible.
2. Process costs should be as low as possible.
3. Risk of contamination by infectious agents and endotoxins should be eliminated.
In the cultivation of animal cells, a basal medium is traditionally supplemented with mammal blood serum. Such serum contains several partly unknown cell growth promoting agents, such as growth factors, vitamins, trace elements, hormones, binding proteins and attachment factors. A serum suitable for most purposes is fetal bovine serum (FBS). The price of this serum has increased greatly in recent years because of the increasing demand and the limited availability of sufficiently pure sera.
The complexity, limited availability and high price of FBS and serious drawbacks in using FBS especially in large scale bioreactor has led to efforts aiming at eliminating FBS as a nutritional supplement. In some cases, FBS can be replaced with newborn calf serum, calf serum or even adult bovine serum. FBS is, however, most effective. This is probably due to its high growth factor content. Other important proteins in serum are attachment factors. These include, for example, fibronectin. Most adherent cell types require additional attachment factors in cell culture medium although some cells can also synthezise them by themselves.
If the objective of growing animal cells is the production, purification and characterization of secreted compounds such as monoclonal antibodies, the use of serum-free medium containing reduced amounts of protein and immunoglobulins makes downstream processing more simple and can greatly improve end-product purification and recovery.
In a paper by R Pakkanen et al. , Appl Microbiol Biotechnol (1992) 37: 451 - 456 has been described a bovine colostrum fraction useful as serum substitute for the cultivation of mouse hybridomas for production of monoclonal antibodies. Fractions of bovine colostrum were prepared and their ability to support the growth of mouse-mouse hybridomas in culture was tested. Whey was prepared from defatted colostrum by removal of casein using acid precipitation. An ultrafiltrate was obtained from cleared whey by filtration through membranes with a nominal molecular weight cut-off of 100000 Da. The colostrum ultrafiltrate (colostrum fraction) so obtained contained 1.16 g/1 protein, 0.24 g/1 im unoglobulin G (IgG) and less than 0.24 EU (endotoxin unit)/ml endotoxins. The effect of defatted colostrum, whey and ultrafiltrate as serum substitutes was studied by cultivation of hybridoma cells in minimal essential medium containing different concentrations of supplements. Under optimal conditions in ultrafiltrate-supplemented medium, the maximal cell concentration was 35 - 40 % of that obtained using 10 % fetal bovine serum, and antibody production per cell was equal to that achieved using fetal bovine serum. The results of this study showed that the bovine colostrum ultrafiltrate provides a very attractive alternative to fetal bovine serum for production of monoclonal antibodies.
An important group of cells used for the production of biochemicals are classified as adherent cells. Animal cells can be divided into two classes according to the manner in which they grow: suspension cells, which grow in suspended form, and adherent cells, which grow attached to a surface. Hybrido a cells are typically suspension cells while most of the other cells could be classified as adherent cells. Typical examples of adherent cells are e.g. Vero (kidney cells of the African Green Monkey), CHO-K1 (ovary cell line of the Chinese hamster) and 3T3-fibroblast. The Vero and CHO-K1-cells are widely used in the biotechnical industry. Vero cells are used in the production of viruses and viral proteins and CHO-K1- and CHO-cells are often used as host cells in large scale production of recombinant proteins.
Bovine colostrum resembles FBS in the respect that it contains growth factors. The growth factor content of colostrum is high. As reported in the above study by R Pakkanen et al. , a colostrum ultrafiltrate could be used to replace FBS in hybridoma cell cultures. On the other hand, colostrum does not contain enough attachment factors for many adherent cells. Such attachment factors can be found in FBS as well as in bovine serum (BS).
The effect of the colostrum ultrafiltrate fraction on the growth of adherent cells has also been tested. Vero and CHO-K1 cells were grown in a basal medium containing varying amounts of colostrum ultrfiltrate according to the method described in the paper by R Pakkanen et al. A minor effect could be observed at colostrum ultrafiltrate concentrations ranging from 10 to 15 %, but the effect was very small compared to that caused to the growth of the hybridoma cells.
It seems therefore clear that the replacement of fetal bovine serum with a colostrum fraction (colostrum ultrafiltrate) as additive to the culture medium does not lead to satisfactory results in the cultivation of adherent cells.
As mentioned above, bovine serum contains the important attachment factor fibronectin. According to US 4,440,860, fibronectin added to colostrum possesses an advantageous effect on the proliferation of adherent cells. However, as will be seen below, the addition of fibronectin to a colostrum fraction according to this invention did not affect the growth of adherent cells.
OBJECT OF THE INVENTION
It is therefore an object of the invention to provide a composition which mixed with the basal medium gives a highly efficient culture medium for the cultivation of adherent cells.
Another object of the invention is to provide an efficient culture medium for the cultivation of such cells.
Yet another object of the invention is to provide a method for the growth of adherent cells, by utilizing the culture medium of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
The Figures IA to 6 describes the number of viable cells versus time during continuous cultivation on a culture medium comprising different attachment factor additive compositions and different amounts thereof. Unless otherwise specified in the presentation of the particular Figures, in the experiments on which the Figures are based the the basal media used were DMEM for Vero cells and DMEM- F12 (1:1) for CHO-K1 cells supplemented with glutamine (4 mM), penicillin (100 units/ml) and streptomycin (100 μg/ml). Unless otherwise specified in the presentation of the particular Figures, in the experiments human transferrin (hTF) was added to the culture medium to give a concentration of 5 mg/1. All the percentages below are vol- %. For further details reference is made to the experiments.
Figure IA shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS (•) and 13 % bovine colostrum ultrafiltrate (in the following abbreviated UF) (0).
Figure IB shows the number of viable Vero-cells versus time in a culture medium supplemented with 10 % FBS (•) and 13 % colostrum ultrafiltrate (in the following abbreviated UF) (0).
Figure 2A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 2 % BS (bovine serum) + 13 % UF (X)
1 % BS + 13 % UF (_i) 0.6 % BS + 13 % UF (■) 0.33 % BS + 13 % UF (▼) 0.1 % BS + 13 % UF (•)
Figure 2B shows the number of viable Vero-cells versus time in a culture medium supplemented with
2 % BS + 13 % UF (X) 1 % BS + 13 % UF (A)
0.6 % BS + 13 % UF (p) 0.33 % BS + 13 % UF () 0.1 % BS + 13 % UF (t) Figure 3A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 1 % BS + 13 % UF (0) 1 % BS + 10 % UF (v) 1 % BS + 6.67 % UF (π) 1 % BS + 3.3 % UF (A)
Figure 3B shows the number of viable Vero-cells versus time in a culture medium supplemented with 1 % BS + 13 % UF (•) 1 % BS + 10 % UF ( ) 1 % BS + 6.7 % UF (■) 1 % BS + 3.3 % UF (_4)
Figure 4A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with
0.5 % BS, no hTF added (•)
1.0 % BS, " (▼)
2.0 % BS, " (■)
1.0 % BS + 6.7 % UF, 5 mg/1 hTF (0) 0.33 % BS + 6.7 % UF, 5 mg/1 hTF (v)
0.60 % BS + 6.7 % UF, 5 mg/1 hTF (D)
1.0 % BS + 10 % UF, 5 mg/1 hTF ( )
Figure 4B shows the number of viable Vero-cells versus time in a culture medium supplemented with 0.5 % BS, no hTF added (t)
1.0 % BS, " ()
2.0 % BS, " (m)
0.66 % BS + 10 % UF, 5 mg/1 hTF (0)
0.33 % BS + 6.7 % UF, 5 mg/1 hTF (v) 0.60 % BS + 6.7 % UF, 5 mg/1 hTF (D)
1.0 % BS + 10 % UF, 5 mg/1 hTF (_Δ)
Figure 5A shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 0.5 % FBS, no hTF added (•) 1.0 % FBS, " (ψ) 2.0 % FBS, no hTH added (B) 10 % FBS, no hTF added (_4) 1.0 % BS + 6.7 % UF, 5 mg/1 hTF (0) 0.33 % BS + 6.7 % UF, 5 mg/1 hTF (V) 0.60 % BS + 6.7 % UF, 5 mg/1 hTF (D) 1.0 % BS + 10 % UF, 5 mg/1 hTF ( .) no supplement of BS, UF or hTF added (X)
Figure 5B shows the number of viable Vero-cells versus time in a culture medium supplemented with 0.5 % FBS, no hTF added (•)
1.0 % FBS, " (ψ)
2.0 % FBS, " (■)
10 % FBS, " (A)
0.66 % BS + 10 % UF, 5 mg/1 hTF (0) 0.33 % BS + 6.7 % UF, 5 mg/1 hTF (V)
0.60 % BS + 6.7 % UF, 5 mg/1 hTF (D)
1.0 % BS + 10 % UF, 5 mg/1 hTF (__.) no supplement of BS, UF or hTF added (X)
Figure 6 shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS (•) 10 % UF (0) 10 % UF + 65 μg/ml of fibronectin (D)
DETAILED DESCRIPTION OF THE INVENTION
It has now surprisingly been found that a composition comprising a colostrum fraction, e.g. the colostrum ultrafiltrate as described in the experiments, and small amounts of serum efficiently enhances the growth of adherent cells when added to the culture medium for said cells. The results obtained clearly exhibit a synergistic effect obtained by combining the two components, i.e. UF and BS. Comparative tests with the addition to the culture medium of plain BS, plain UF and various combinations of UF and BS show that the combinations give an essentially stronger effect on the growth of the adherent cell than what would be expected by adding the effects of the individual components UF and BS.
The invention thus provides a composition useful as additive to culture media for the cultivation of adherent cells, said composition comprising
- a colostrum fraction prepared by subjecting colostrum, from which fat and cellular debris have been removed by conventional methods, and from which colostrum optionally also casein has been removed by precipitation, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate, and
- a serum component in an amount sufficient to enhance the proliferation of cells after the addition of a suitable amount of said composititon to a culture medium.
The invention further provides a culture medium useful for the cultivation of adherent cells, said culture medium comprising
- a basal growth medium,
- a colostrum fraction prepared by subjecting colostrum, from which fat and cellular debris have been removed by conventional methods, and from which colostrum optionally also casein has been removed by precipitation, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate,
- a serum component, and optionally
- additional transferrin and other supplemental agents.
The invention further provides a method of promoting proliferation of adherent cells in a culture medium said method comprising contacting an amount of cells with a culture medium according to the invention for a certain period of time.
For the cultivation of certain cells, e.g. Vero cells, the transferrin present in the serum may be enough. For other cells such as CHO-Kl-cells, however, the culture medium must be supplemented by additional transferrin.
The colostrum fraction is for practical reasons preferably obtained from bovine colostrum. Colostrum from other sources is, however, also believed to be useful for the preparation of the colostrum fraction to be used in this inventio .
The serum component is preferably bovine serum, but other sera such as horse sera are also believed to be effective.
According to a preferred embodiment of the invention, the colostrum fraction has an endotoxin content of less than 5 EU/ l (units per ml), a total protein content of less than 4.5 mg/ml and an immunoglobulin content of less than 1.2 mg/ml.
Particularly preferable are compositions of the invention wherein the colostrum fraction has an endotoxin content of 1.0 EU/ml or less, a total protein content of 2.0 mg/ml or less and an immunoglobulin content of 0.25 mg/ml or less. Such a fraction can be obtained by e.g. by subjecting the defatted colostrum to casein precipitation before the ultrafiltration.
The composition of the invention comprises preferably serum component in an amount of at least 0.5 % of said composition.
The composition according to the invention can further comprise one or more supplemental agents selected from the group comprising sodium selenite, ethanolamine, β- mercaptoethanol, bovine serum albumin and transferrin.
Although the culture medium of this invention can be prepared by adding separately appropriate amounts of colostrum fraction and serum to the basal growth medium, the culture medium is preferably made by adding to the basal growth medium an appropriate amount of a composition redily including the colostrum fraction and serum component. According to a particularly preferred embodiment, the composition further includes added amounts of transferrin and optionally also other supplemental agents.
According to a further preferred embodiment, the culture medium has a concentration of the colostrum fraction ranging from about 1 % to about 20 % and a serum concentration that is at least 0.1 % of said culture medium.
Most preferably, the culture medium has a concentration of the colostrum fraction ranging from about 5 to 15 % of said culture medium.
Although the method of promoting proliferation of cells in a culture medium according to the invention is useful in the cultivation of adherent cells generally it is especially advantageous for the cultivation of adherent cells such as CH0-K1 (Chinese hamster ovary cells) and Vero (African green monkey kidney cells) as these two represent the technically most important adherent cells.
EXPERIMENTS
The aim of the experiments presented below is to show that a composition of bovine serum (BS) and a bovine colostrum fraction, colostrum ultrafiltrate (UF), can support proliferation of adherent cells.
Materials and methods
Cells
Chinese hamster ovary cells (CHO-K1, ATCC CCL 61) and African green monkey kidney cells (Vero, ATCC CCL 81) were obtained from Flow (Flow Laboratories, Rickmansworth, England) .
Cell cultivation
The basal media used were Dulbecco's Modified Eagles Essential Medium (DMEM) (for Vero cells) (GIBCO Life
Technologies Inc., Paisley, Scotland) and DMEM-F12 (1:1) (GIBCO) (for CHO-K1 cells) supplemented with glutamine (4 mM), penicillin (100 units/ml) and streptomycin (100 μg/ml). Stock cultures were maintained in 75-cm2 plastic flasks (Cos ar, Cambridge, Mass, USA) supplemented with 10 % FBS (HyClone, Logan, Utah, USA).
For subculture, cells growing at mid or late exponential phase were washed with the basal medium and detached from culture flasks by incubation with trypsin (0.05 %)-EDTA (0.53 mM) (TE) (GIBCO). The cells were suspended in the basal and aliquots of the cell suspension were added to media supplemented with known amounts of adult bovine serum (BS) (SIGMA, St. Louis, MO, USA), fetal bovine serum (FBS) or colostrum ultrafiltrate (UF) (for the preparation of UF, see R Pakkanen et al. , Appl Microbiol Biotechnol (1992) 37: 451 - 456) and human (holo)transferrin (5 mg/1) (SIGMA). The cells were plated in the test media into 24-well plates (Costar) at a concentration of 20 000 viable cells/well (1.5 ml/well) and incubated without medium change for different time periods.
For cell counting, the culture supernatants were removed and 150 μl 2xTE was added to each well. The plates were incubated at 37°C for about 10 min. Then, the culture supernatants were added back to the corresponding wells and the cells were suspended by pipetting the cultures. Cell counts were done in a haemocytometer using trypan blue exclusion to determine viability. Each counting point represents the average cell concentration of duplicate wells, and each well was counted only once.
RESULTS
Cell growth in 10 % FBS and in 13 % UF
To study the cell growth in UF supplemented DMEM CHO-K1 and Vero cell were first cultured in 10 % FBS or in 13 % UF supplemented with transferrin 5 mg/1 for 14 days. The results (Fig. 1) showed that both the Vero and CHO-K1 cells could not grow in UF supplemented medium. The reason for this was the inability of the cells to attach to plastic in UF. This is in correlation with a previous finding that bovine colostrum contains only a negligible amount of fibronectin, a major attachment factor present in serum (Steimer and Klagsbrun, J. Cell. Biol. (1981) 88: 294-300.
Cell growth in 13 % UF supplemented with 0.1-2 % BS
To study the effect of a small amount of adult bovine serum on cell growth CH0-K1 and Vero cells were cultured in 13 % UF supplemented with 0.1-2 % BS and transferrin 5 mg/1. The results (Fig. 2) indicated that even 0.33 % additional BS enhance dramatically the growth of both cell lines. 0.1 % additional BS was not effective. In the cultures supplemented with > 0.6 % BS and 13 % the cells were well spread and their morphology resembles to that in 10 % FBS. This suggests that the growth factors provided by UF and the attachment factors provided by BS can support the growth of the adherent Vero and CH0-K1 cells. In 0.33 % FBS CH0-K1 cells tended to form large clusters and only a small cell population was spread. Maximum growth of Vero cells was obtained in 13 % UF supplemented with 1-2 % BS, whereas no significant differences could be observed in CHO-K1 cultures supplemented with 0.6-2 % BS.
Cell growth in 1 % BS supplemented with 3.3-13 % UF
To optimize further the concentration of UF and BS Vero and CH0-K1 cells were cultured in 1 % BS supplemented with 3.3- 13 % UF and transferrin 5 mg/1. The results (Fig. 3) indicated that the concentration of UF in the mixture was not so critical. No significant differences were detected in the growth of Vero cells in the different mixtures. CHO- Kl cells achieved maximum cell density in 6.7 % UF.
Growth promoting activity of BS compared with that of OF supplemented with BS
To study the synergistic effect of UF and BS Vero and CHO- Kl cells were cultured in 0.5-2 % BS and in four combinations of BS and UF supplemented with human transferrin. The results (Fig. 4) showed that CHO-K1 cells did not grow in BS and also Vero cells exhibited significantly better growth in different mixtured of UF and BS compared with that in BS supplemented media.
Growth promoting activity of FBS compared with that of UF supplemented with BS
To compare the growth promoting activity of different mixtures of BS and UF with that of FBS the cells were cultivated in four combinations of UF and BS (supplemented with transferrin) and in 0.5-10 % FBS. The results (Fig. 5) showed that the maximum cell densities obtained in different combinations of UF and BS were about 70-110 % of that obtained in 1-10 % FBS. In 0.5 % FBS cell growth was significantly reduced. Figure 6 shows the number of viable CHO-Kl-cells versus time in a culture medium supplemented with 10 % FBS, 10 % UF and 10 % UF + 65 μg/ml of fibronectin. As can be seen from the Figure, fibronectin added to the UF did not have any effect on the cell growth.
The colostrum fraction from which casein not has been removed before ultrafiltration, which fraction also is useful in the composition and culture medium of the invention, is prepared according to the method described in the paper by R Pakkanen et al. referred to above with the only difference that casein is not precipitated before ultrafiltration.

Claims

1. A composition useful as additive to culture media for the cultivation of adherent cells, said composition comprising
- a colostrum fraction prepared by subjecting colostrum, from which part of the fat and cellular debris have been removed by conventional methods, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate, and
- a serum component in an amount sufficient to enhance the proliferation of cells after the addition of a suitable amount of said composititon to a culture medium.
2. The composition according to claim 1 where casein has been removed from the colostrum before the ultrafiltration.
3. The composition according to claim 1 wherein the colostrum fraction is a bovine colostrum fraction and the serum component is bovine serum.
4. The composition according to claim 1 wherein the colostrum fraction has an endotoxin content of less than 5 EU/ml, a total protein content of less than 4.5 mg/ml and an immunoglobulin content of less than 1.2 mg/ml.
5. The composition according to claim 2 wherein the colostrum fraction has an endotoxin content of 1.0 EU/ml or less, a total protein content of 2.0 mg/ml or less and an immunoglobulin content of 0.25 mg/ml or less.
6. The composition according to claim 5 wherein the serum component is present in an amount of at least 0.5 % of said composition.
7. The composition according to claim 6 wherein said composition further comprises one or more supplemental agents selected from the group comprising sodium selenite, ethanolamine, β-mercaptoethanol, bovine serum albumin and transferrin.
8. A culture medium useful for the cultivation of adherent cells, said culture medium comprising
- a basal growth medium,
- a colostrum fraction prepared by subjecting colostrum, from which fat and cellular debris have been removed by conventional methods, to ultrafiltration by using a membrane having a cut off of 100,000 Da and recovering the filtrate, and
- a serum component.
9. The culture medium according to claim 8 wherein casein has been removed from the colostrum before the ultrafiltration.
10. The culture medium according to claim 9 which further comprises additional transferrin and other supplemental agents.
11. The culture medium according to claim 9 wherein the colostrum fraction is a bovine colostrum fraction and the serum component is bovine serum.
12. The culture medium according to claim 8 wherein the colostrum fraction has an endotoxin content of less than 5 EU/ml, a total protein content of less than 4.5 mg/ml and an immunoglobulin content of less than 1.2 mg/ml.
13. The culture medium according to claim 9 wherein the colostrum fraction has an endotoxin content of 1.0 EU/ml or less, a total protein content of 2.0 mg/ml or less and an immunoglobulin content of 0.25 mg/ml or less.
14. The culture medium according to claim 13 wherein the concentration of the colostrum fraction ranges from about 1 % to about 20 % and the serum concentration is at least 0.1 % of said culture medium.
15. The culture medium according to claim 14 wherein the concentration of the colostrum fraction ranges from about 5 to 15 % of said culture medium.
16. A culture medium useful for the cultivation of adherent cells, said culture medium comprising a basal growth medium and a composition according to any one of claims 1 to 7.
17. The culture medium according to claim 16 wherein said composition is present in an amount sufficient to give a serum concentration of at least 0.1 % of said culture medium.
18. The culture medium according to claim 17 wherein said composition is present in an amount sufficient to give a colostrum fraction concentration ranging from about 1 % to about 20 % of said culture medium.
19. The culture medium according to claim 18 wherein said composition is present in an amount sufficient to give a colostrum fraction concentration ranging from 5 to 15 % of said culture medium.
20. A method of promoting proliferation of adherent cells in a culture medium said method comprising contacting an amount of cells with a culture medium according to claim 8 for a certain period of time.
21. A method of promoting proliferation of adherent cells in a culture medium said method comprising contacting an amount of cells with a culture medium according to claim 16 for a certain period of time.
22. The method according to claim 21 wherein the cells are Vero cells.
23. The method according to claim 21 wherein the cells are CH0-K1 cells.
PCT/FI1994/000089 1993-04-01 1994-03-11 A composition useful as additive to a cell culture medium, comprising colostrum and serum WO1994023017A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU62091/94A AU6209194A (en) 1993-04-01 1994-03-11 A composition useful as additive to a cell culture medium, comprising colostrum and serum
EP94909138A EP0692023A1 (en) 1993-04-01 1994-03-11 A composition useful as additive to a cell culture medium, comprising colostrum and serum

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4165893A 1993-04-01 1993-04-01
US08/041,658 1993-04-01

Publications (1)

Publication Number Publication Date
WO1994023017A1 true WO1994023017A1 (en) 1994-10-13

Family

ID=21917670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI1994/000089 WO1994023017A1 (en) 1993-04-01 1994-03-11 A composition useful as additive to a cell culture medium, comprising colostrum and serum

Country Status (4)

Country Link
EP (1) EP0692023A1 (en)
AU (1) AU6209194A (en)
EE (1) EE03162B1 (en)
WO (1) WO1994023017A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619990A1 (en) * 1996-05-17 1997-11-20 Charlotte Adler Process for the production of colostral milk products and their use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) * 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
WO1992000014A1 (en) * 1990-06-28 1992-01-09 Clar (Sarl) Method for treating colostrum by hydroxyapatite adsorption chromatography, an active fraction of colostrum thereby obtained, and a cellular medium containing same
WO1993008264A1 (en) * 1991-10-17 1993-04-29 Valio Bioproducts Ltd. Colostrum fraction, preparation and use thereof as cell culture media supplement

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) * 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
WO1992000014A1 (en) * 1990-06-28 1992-01-09 Clar (Sarl) Method for treating colostrum by hydroxyapatite adsorption chromatography, an active fraction of colostrum thereby obtained, and a cellular medium containing same
WO1993008264A1 (en) * 1991-10-17 1993-04-29 Valio Bioproducts Ltd. Colostrum fraction, preparation and use thereof as cell culture media supplement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619990A1 (en) * 1996-05-17 1997-11-20 Charlotte Adler Process for the production of colostral milk products and their use

Also Published As

Publication number Publication date
AU6209194A (en) 1994-10-24
EP0692023A1 (en) 1996-01-17
EE03162B1 (en) 1999-02-15

Similar Documents

Publication Publication Date Title
EP0703978B1 (en) Medium for long-term proliferation and development of cells
Keen et al. Development of a serum-free culture medium for the large scale production of recombinant protein from a Chinese hamster ovary cell line
RU2536244C2 (en) Medium for cultivation of cells without proteins and serum
US5324656A (en) Media for normal human muscle satellite cells
Chuman et al. Continuous growth of proximal tubular kidney epithelial cells in hormone-supplemented serum-free medium.
AU702871B2 (en) (In vitro) growth of neutrophil and megakaryocyte precursors in serum-free media
US6037174A (en) Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
JP2629074B2 (en) Colostrum fraction, method for its preparation and its use as a supplement for cell culture media
Kan et al. In vitro proliferation and lifespan of human diploid fibroblasts in serum‐free BSA‐containing medium
JP2006288407A (en) Hematopoietic cell culture nutrient supplement
CA1199578A (en) Tissue culture medium
Stohl Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use.
Keen et al. The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker
WO1994023017A1 (en) A composition useful as additive to a cell culture medium, comprising colostrum and serum
US5409827A (en) Blended bovine sera cellular growth media and their methods of production and use
EP1059352A1 (en) Long term cell culture of human carcinoma
Pakkanen Bovine colostrum ultrafiltrate supplemented with adult bovine serum and transferrin: an effective fbs substitute for cultivation of Vero and CHO-K1 cells
EP0115284A2 (en) Tissue culture medium
CA1340953C (en) Non-tumorigenic cell lines for expression of genes
WO1994018310A1 (en) Growth enhancing media supplement for the culture of mammalian cells
KR880002318B1 (en) Serum-free medium
Côte et al. Protein-free culture medium improvement: testing additives and their interactive effects in 96-well plates
Togami et al. Serum-free medium for murine and human lymphoid and hybridoma cell lines
Hunter Actions of CNS neuronal cell line-conditioned medium on oligodendrocyte-type 2 astrocyte lineage cells in vitro
AU8338082A (en) Tissue culture medium

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KP KR KZ LK LU LV NL NO NZ PL PT RO RU SE SI SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994909138

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994909138

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1994909138

Country of ref document: EP